Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

SARS-CoV-2

Natural killer cells limit antibody protection

Nature Immunology volume 26, pages 2118–2119 (2025)Cite this article

Subjects

Interferon-activated natural killer cells attack the immune helpers that support antibody development against multiple SARS-CoV-2 variants.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: IFN boosts NK cell killing of the T cells that help develop antibodies with breadth.

References

  1. Rydyznski, C. E. et al. Cell Rep. 24, 3367–3373.e4 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Gyurova, I. E., Ali, A. & Waggoner, S. N. Viral Immunol. 33, 334–341 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. de los Rios Kobara, I. et al. Nat. Immunol. https://doi.org/10.1038/s41590-025-02341-1 (2025).

  4. Kumar, S. et al. Sci. Adv. 10, eadq7006 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Planas, D. et al. Nature 602, 671–675 (2022).

    Article  PubMed  CAS  Google Scholar 

  6. Garcia-Beltran, W. F. et al. Cell 184, 2372–2383.e9 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Barnes, S. A. et al. Front. Immunol. 13, 1050718 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Pi, R. et al. iScience 28, 113548 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Guo, A.-L. eBioMedicine 75, 103794 (2022).

    Article  PubMed  CAS  Google Scholar 

  10. Suhito, I. R., Sunil, C. & Tay, A. Bioact. Mater. 44, 164–183 (2025).

    PubMed  CAS  Google Scholar 

  11. Bradley, T. et al. Cell 175, 387–399.e17 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Casanova, J.-L. & Anderson, M. S. J. Clin. Invest. 133, e166283 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Massachusetts Chan Medical School, Worcester, MA, USA

    Kiera L. Clayton

Authors
  1. Kiera L. Clayton
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Kiera L. Clayton.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clayton, K.L. Natural killer cells limit antibody protection. Nat Immunol 26, 2118–2119 (2025). https://doi.org/10.1038/s41590-025-02349-7

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41590-025-02349-7

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing